Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap11
Vector
Dependencies
Next steps
- 7 Vectored vaccines
- 7A Safety
- 7B Delivery route
- 7C Delivery platform
- 7D Efficacy in challenge model
Identifying suitable vector for the expression/delivery of protective PRRSV Antigens
Research Question
- The generation of protective responses without the risk of the recombination between an attenuated strain and wild strains
Research Gaps and Challenges
- The expression of the protective antigens by a replicating organism with the development of VN-Abs and CTC responses
- Creating stable genetically modified organisms expressing the desired PRRSV antigens
- Identifying the Ag combination to give widest protection against the various field isolates
Solution Routes
- Generation of genetically modifies organisms (viruses or bacteria) expressing the protective antigens of different PRRSV strains
- Incorporation of molecular adjuvants (expressing CD40 ligand)
Dependencies
- Identity of the most appropriate antigens
Projects
What activities are planned or underway?
Generating antibodies broadly neutralising porcine reproductive and respiratory syndrome virus (PRRSV)
Planned Completion date 31/12/2025
Source Countries:
Denmark
Identification of interferon stimulated genes that control Toxoplasma in pig macrophages
Planned Completion date 01/03/2026
Source Countries:
United Kingdom